Diabetes Research Centers (P30) | RFA DK 15 026

Opportunity Information: Apply for RFA DK 15 026

The Diabetes Research Centers (P30) funding opportunity (RFA-DK-15-026) is a National Institutes of Health (NIH) grant program administered through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). It supports institution-based Diabetes Research Centers intended to strengthen and accelerate research on diabetes, diabetes-related complications, and closely connected endocrine and metabolic diseases. The basic idea is to concentrate shared resources and coordinated activities in one center so investigators can work more efficiently, collaborate across disciplines, and generate stronger, more impactful science than they could by operating in isolation.

This FOA is specifically for P30 Center grants, which are designed to provide shared infrastructure rather than funding a single research project. The Centers are expected to enhance the national diabetes research effort by improving access to specialized facilities, expertise, services, and coordinated scientific programming. Historically, these Centers were known as Diabetes Endocrinology Research Centers (DERCs) and Diabetes Research and Training Centers (DRTCs), and this announcement reflects the continued evolution of that same national program. In 2015, the NIDDK Diabetes Research Centers program consisted of 16 Centers at research institutions with well-documented excellence in diabetes-related research, and the FOA points applicants to www.diabetescenters.org for broader program information.

The program is organized around three main, research-enabling components. First are Research Core services, which are shared scientific cores that provide specialized technologies, methods, services, or resources used by multiple investigators (for example, advanced metabolic phenotyping, biostatistics, clinical data management, imaging, tissue processing, omics platforms, animal models, or other shared capabilities depending on the institution and center focus). These cores are meant to reduce duplication, standardize methods, improve rigor and efficiency, and make high-value capabilities broadly accessible to diabetes investigators at the applicant institution.

Second is the Pilot and Feasibility (P and F) program, which is essentially a small-grants engine within the Center. The P and F component supports early-stage, innovative, and potentially high-impact ideas that can lead to larger independent grants later. These awards often help new investigators establish a foothold in diabetes research, encourage established scientists to pivot into diabetes-focused questions, or allow teams to generate the key preliminary data needed for competitive R01 or equivalent applications. The emphasis is on catalyzing new directions and de-risking bold concepts, not on funding long-term, fully mature projects.

Third is the Enrichment program, which supports activities that build and connect the diabetes research community. While the FOA description is brief, enrichment in center programs typically includes seminars, visiting speaker series, workshops, symposia, career development and mentoring events, and other activities that promote multidisciplinary collaboration, improve the flow of ideas across basic, translational, and clinical research, and increase the overall effectiveness and visibility of the institution's diabetes research ecosystem. In combination, these three elements are intended to raise the quality and productivity of research by making it easier for investigators to share tools, share knowledge, launch new projects, and collaborate across departments and specialties.

Eligibility is broad across domestic U.S. organizational types, consistent with NIH practice for many center mechanisms. Eligible applicants listed include state, county, city, township, and special district governments; public and state-controlled institutions of higher education; private institutions of higher education; independent school districts; federally recognized Native American tribal governments; Native American tribal organizations (other than federally recognized tribal governments); public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly highlights additional eligible categories such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, and U.S. territories or possessions.

At the same time, there are clear restrictions regarding foreign involvement. Non-domestic (non-U.S.) entities (foreign institutions) are not eligible to apply. Non-domestic components of U.S. organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. In practice, this means the applicant organization and the center-supported infrastructure must be U.S.-based without foreign components operating as part of the award.

From an administrative standpoint, this is a discretionary grant opportunity in the health and nutrition category, associated with CFDA number 93.847. The NIH is the awarding agency. The FOA record lists an award ceiling of $1,000,000 and an expectation of approximately 3 awards. The opportunity was created on 2015-10-06 with an original closing date of 2016-05-26. As with many NIH center programs, awards are competitive and typically go to institutions that can demonstrate a strong, ongoing base of diabetes-related research and a clear plan for how shared cores, pilot funding, and enrichment activities will measurably improve scientific output and collaboration.

Overall, the P30 Diabetes Research Centers program is best understood as a platform grant: it funds the shared environment that makes multiple diabetes investigators more successful. Rather than paying for one lab's specific aims, it pays for coordinated resources, pilot funding, and community-building activities that collectively expand an institution's capacity to produce high-quality, multidisciplinary diabetes research and to move discoveries more efficiently from fundamental biology to clinical and public health impact.

• The National Institutes of Health in the food and nutrition, health sector is offering a public funding opportunity titled "Diabetes Research Centers (P30)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847.
• This funding opportunity was created on 2015-10-06.
• Applicants must submit their applications by 2016-05-26. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
• The number of recipients for this funding is limited to 3 candidate(s).
• Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.

Apply for RFA DK 15 026

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: